公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10 | Chen, Chien-Yuan ; SHANG-YI HUANG ; JIH-LUH TANG ; WOEI TSAY ; MING YAO ; BOR-SHENG KO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; PO-REN HSUEH | Journal of Antimicrobial Chemotherapy | 26 | 25 | |
2012 | The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution | SHANG-JU WU ; Kuo Y.-Y.; HSIN-AN HOU ; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; WOEI TSAY ; HWEI-FANG TIEN | Blood | 123 | 100 | |
2007 | Clinical implications of minimal residual disease monitoring by quantitative polymerase chain reaction in acute myeloid leukemia patients bearing nucleophosmin (NPM1) mutations | WEN-CHIEN CHOU ; JIH-LUH TANG ; SHANG-JU WU ; WOEI TSAY ; MING YAO ; SHANG-YI HUANG ; KUO-CHIN HUANG ; Chen, Chien-Yuan ; Huang C.-F.; HWEI-FANG TIEN | Leukemia | 94 | 90 | |
2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 57 | 42 | |
2014 | Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study | Kim K.; Lee J.H.; Kim J.S.; Min C.K.; Yoon S.S.; Shimizu K.; Chou T.; Kosugi H.; Suzuki K.; Chen W.; Hou J.; Lu J.; Huang X.-J.; SHANG-YI HUANG ; Chng W.J.; Tan D.; Teoh G.; Chim C.S.; Nawarawong W.; Siritanaratkul N.; Durie B.G. | American Journal of Hematology | 79 | 75 | |
1997 | Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): A study of four Chinese patients in Taiwan | SHANG-YI HUANG ; JIH-LUH TANG ; Liang Y.-J.; Wang C.-H.; YAO-CHANG CHEN ; HWEI-FANG TIEN | British Journal of Haematology | 41 | 38 | |
2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
1998 | Clonal disease of natural killer large granular lymphocytes in Taiwan | WEN-CHIEN CHOU ; Chiang I.-P.; JIH-LUH TANG ; Su I.-J.; SHANG-YI HUANG ; YAO-CHANG CHEN ; Liu M.-C.; Lee F.-Y.U.; Wang C.-H.; MING-CHING SHEN ; Chuang S.-M.; HWEI-FANG TIEN | British Journal of Haematology | 15 | 11 | |
2009 | Combination of tissue harmonic sonography, real-time spatial compound sonography and adaptive image processing technique for the detection of carotid plaques and intima-medial thickness | Yen C.-L.; Chang H.-Y.; SHANG-YI HUANG ; Huang Y.-C.; Jeng C.-M. | European Journal of Radiology | 11 | 10 | |
2008 | Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies | TAI-CHUNG HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; CHIUN HSU ; Chen, Chien-Yuan ; WOEI TSAY ; SHANG-YI HUANG ; MING YAO ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; HWEI-FANG TIEN | Leukemia | 47 | 42 | |
2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | FENG-MING TIEN ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chen, Chien-Yuan ; CHENG-HONG TSAI ; MING YAO ; Lin, Chien-Ting; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 25 | 21 | |
2017 | Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial | Lu J.; Lee J.H.; SHANG-YI HUANG ; Qiu L.; Lee J.-J.; Liu T.; Yoon S.-S.; Kim K.; Shen Z.X.; Eom H.S.; Chen W.M.; Min C.K.; Kim H.J.; Lee J.O.; Kwak J.Y.; Yiu W.; Chen G.; Ervin-Haynes A.; Hulin C.; Facon T. | British Journal of Haematology | 10 | 11 | |
2012 | Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma | SHANG-YI HUANG ; BANG-BIN CHEN ; Lu H.-Y.; Lin H.-H.; Wei S.-Y.; SZU-CHUN HSU ; TIFFANY TING-FANG SHIH | American Journal of Hematology | 17 | 11 | |
2018 | Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: Subgroup analyses of the phase 3 POLLUX study | Suzuki K.; Dimopoulos M.A.; Takezako N.; Okamoto S.; Shinagawa A.; Matsumoto M.; Kosugi H.; Yoon S.-S.; SHANG-YI HUANG ; Qin X.; Qi M.; Iida S. | Blood Cancer Journal | 21 | 23 | |
2020 | Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study-Asian Subgroup Analysis | SHANG-YI HUANG ; Yoon S.-S.; Shimizu K.; Chng W.J.; Chang C.-S.; Wong R.S.-M.; Gao S.; Wang Y.; Gordon S.W.; Glennane A.; Min C.-K. | Advances in Therapy | 11 | 8 | |
2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 179 | 173 | |
2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 176 | 160 | |
2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 195 | 184 | |